5-amino-4-(2-azepanylidene)-2-phenyl-2,4-dihydro-3h-pyrazol-3-one,
EN300-02612,
5-Amino-2-phenyl-4-(4,5,6,7-tetrahydro-3H-azepin-2-yl)-2H-pyrazol-3-ol,
926205-33-6,
AC1LEXSB,
CTK7E1357,
HMS1784B07,
AC1Q5321,
ZINC5731544,
STK973507,
STL228991,
STL265150,
AKOS000122091,
AKOS002230596,
AKOS002346240,
AKOS002528854,
ZINC100429712,
ZINC100857336,
ZINC103962734,
MCULE-5712898156,
ST50114273,
SR-01000031790,
SR-01000031790-1,
(4Z)-5-amino-4-(2-azepanylidene)-2-phenyl-2,4-dihydro-3H-pyrazol-3-one,
(4Z)-5-amino-4-(azepan-2-ylidene)-2-phenyl-2,4-dihydro-3H-pyrazol-3-one,
1-Phenyl-3-amino-4-(hexahydro-1H-azepine-2-ylidene)-2-pyrazoline-5-one,
3-amino-1-phenyl-4-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1H-pyrazol-5-ol,
3-amino-4-(2,3-dihydro-4H,5H,6H-azepin-7-yl)-1-phenyl-3-pyrazolin-5-one,
5-amino-2-phenyl-4-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1,2-dihydro-3H-pyrazol-3-one,
5-amino-2-phenyl-4-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1H-pyrazol-3-one,
CID719736,
ZINC03885563,